Kristi Cartwright
Acute Care · Virginia Beach, VANPI 1922360718
Payments from drug & device makers
Across 83 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$665
- Merz Pharmaceuticals, LLC$143
- Lundbeck LLC$140
- Lilly USA, LLC$119
- Abbott$81
- Biohaven Pharmaceuticals, Inc.$76
- plus $485 from 17 others
What the payments were for
- Food & beverage$1,709100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $665 |
| Merz Pharmaceuticals, LLC | 5 | $143 |
| Lundbeck LLC | 5 | $140 |
| Lilly USA, LLC | 5 | $119 |
| Abbott | 4 | $81 |
| Biohaven Pharmaceuticals, Inc. | 4 | $76 |
| Bioventus LLC | 2 | $68 |
| Novartis | 3 | $54 |
| Curonix LLC | 2 | $46 |
| Biodelivery Sciences International, Inc. | 3 | $45 |
| Nevro Corp. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $22 |
| Avanos Medical | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Vertex | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
How this compares
$1,709 in reported general payments places this provider in the 80th percentile of 599 acute care providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 36 | $10,534 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $2,817 |
| Lidocaine | 15 | $2,377 |
| Tramadol Hcl | 139 | $2,021 |
| Pregabalin | 64 | $1,960 |
| Gabapentin | 139 | $1,915 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $1,510 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 36 | $1,355 |
| Oxycodone Hcl | 54 | $741 |
| Cyclobenzaprine Hcl | 47 | $419 |
| Tizanidine Hcl | 32 | $236 |
| Ropinirole Hcl | 12 | $226 |
| Duloxetine Hcl | 15 | $198 |
| Celecoxib | 17 | $192 |
| Meloxicam | 11 | $187 |
Paid to pharmacies, not to this prescriber.
Other acute care in Virginia Beach
- Rachel DukeRichmond$751K
- Julia KingNorfolk$99K
- Sarah KennedyNorfolk$57K
- Sarah W ShermanNorth Chesterfield$41K
- Tamara StephensDeltaville$30K
- Debra CastnerNassawadox$28K
- Linda HartMidlothian$21K
- Mica FerlisRichmond$20K
- Corinnia WagnerFredericksburg$18K
- Tonja StevensArlington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.